Lina Wang, MD
Anatomic Pathology & Clinical Pathology · Los Angeles, CANPI 1447266317
Payments from drug & device makers
What this record shows
4 manufacturers reported payments, led by Agilent Technologies, Inc. at 56.2% of the total. Reporting peaked in 2019 at $334 and has fallen 63.1% since, to $123 in 2025.
Across 7 payments — averaging $84.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Agilent Technologies, Inc.$334
- Phathom Pharmaceuticals, Inc.$123
- AstraZeneca$117
- Kyowa Kirin, Inc.$20
Across 21 payments — averaging $13,314 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ventana Medical Systems, Inc.$280K
What the payments were for
- Travel & lodging$29449%
- Food & beverage$30051%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Agilent Technologies, Inc. | 4 | $334 |
| Phathom Pharmaceuticals, Inc. | 1 | $123 |
| AstraZeneca | 1 | $117 |
| Kyowa Kirin, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PD-L1 IHC 22C3$294
- VOQUEZNA$123
- ANDEXXA$117
How this compares
$594 in reported general payments places this provider in the 75th percentile of 814 anatomic pathology & clinical pathology providers in California.
See all anatomic pathology & clinical pathology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in Los Angeles
- Serge AlexanianLos Angeles$3.2M
- Brian ConeLos Angeles$519K
- Michael LewisLos Angeles$220K
- Mark HaasLos Angeles$175K
- Fausto RodriguezLos Angeles$87K
- Scott NelsonLos Angeles$81K
- Nam KuLos Angeles$80K
- Jess SavalaLos Angeles$62K
- Elias MakhoulLos Angeles$41K
- Maria del Carmen Frias KleteckaLos Angeles$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.